Healthcare
AER Therapeutics
View On Demand
5 million COPD patients experiencing airway blockages can be treated with Aer-01 from Aer Therapeutics
Menu
5 million COPD patients experiencing airway blockages can be treated with Aer-01 from Aer Therapeutics
The diagnostic market for stress-related diseases is $60B. Inmedix has developed a way to measure stress with two recurrent revenue streams and 90% SaaS margins.
Immunicom has developed a hybrid cancer therapy which combines the best of a medical device with targeted drug therapy
Dr. John Abeles and Bryologyx CEO, Thomas Loarie, share their best practices in healthcare investing.
Learn more about Preverna’s revolutionary approach to cancer drug development and how they’re working with others to improve cancer care.
Invectys President and CEO, Praveen Tyle, discuses the company’s three platforms and the technology that has the potential to cure metastatic cancers
Walter Ulrich, President & CEO of Medical Bridges shares the challenges, issues, and many successes of distributing medical equipment Ukraine.
Inmedix CEO, Andrew J. Holman, MD discusses the company’s upcoming milestones and how their approach to stress testing will transform rheumatology and several other medical specialties.
Assembly Bio President and CEO, Dr. John McHutchison discusses the company’s multi-platform approach to curing HBV and the major inflection points ahead this year and next.
Bryologyx Founder and CEO, Thomas Loarie discusses the importance of bryostatin, a platform of tumor and antigen stimulating drugs that improve the efficacy of cancer immunotherapies
1460 Broadway
New York, NY 10036
(917) 747-6198
© Copyright 2021 FORCE Family Office